QSAM Biosciences, Inc.
QSAM · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $0 | $0 | $0 | $0 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $0 | $0 | $0 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 0% | – | – | – |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -39.7% | – | – | – |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -44% | – | – | – |
| EPS Diluted | -0.13 | -0.36 | -0.43 | -0.9 |
| % Growth | 63.9% | 16.3% | 52.2% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |